| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | NCOA6 GTF2H1 TCF7L2 EGR2 MED25 NCOA1 HSD17B10 ARID1A CREBBP EP300 RAD23B | 4.73e-08 | 417 | 61 | 11 | GO:0061629 |
| GeneOntologyMolecularFunction | nuclear receptor binding | 9.81e-08 | 187 | 61 | 8 | GO:0016922 | |
| GeneOntologyMolecularFunction | chromatin binding | RAG2 NCOA6 GTF2H1 TCF7L2 EGR2 GLI3 NCOA1 RCC1 CHD8 ARID1A CREBBP EP300 MSGN1 | 2.80e-07 | 739 | 61 | 13 | GO:0003682 |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | NCOA6 GTF2H1 TCF7L2 EGR2 MED25 NCOA1 HSD17B10 ARID1A CREBBP EP300 RAD23B | 1.31e-06 | 582 | 61 | 11 | GO:0140297 |
| GeneOntologyMolecularFunction | transcription coactivator activity | 3.76e-06 | 303 | 61 | 8 | GO:0003713 | |
| GeneOntologyMolecularFunction | peptide lactyltransferase (CoA-dependent) activity | 9.18e-06 | 2 | 61 | 2 | GO:0120300 | |
| GeneOntologyMolecularFunction | histone H3K27 acetyltransferase activity | 9.18e-06 | 2 | 61 | 2 | GO:0044017 | |
| GeneOntologyMolecularFunction | transcription factor binding | NCOA6 GTF2H1 TCF7L2 EGR2 MED25 NCOA1 HSD17B10 ARID1A CREBBP EP300 RAD23B | 1.52e-05 | 753 | 61 | 11 | GO:0008134 |
| GeneOntologyMolecularFunction | histone H3K18 acetyltransferase activity | 2.75e-05 | 3 | 61 | 2 | GO:0043993 | |
| GeneOntologyMolecularFunction | peroxisome proliferator activated receptor binding | 3.47e-05 | 21 | 61 | 3 | GO:0042975 | |
| GeneOntologyMolecularFunction | nuclear retinoid X receptor binding | 4.60e-05 | 23 | 61 | 3 | GO:0046965 | |
| GeneOntologyMolecularFunction | transcription coregulator activity | 4.89e-05 | 562 | 61 | 9 | GO:0003712 | |
| GeneOntologyMolecularFunction | histone modifying activity | 6.99e-05 | 229 | 61 | 6 | GO:0140993 | |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | HEYL POU6F2 TCF7L2 ZNF628 EGR2 ZNF41 ZNF174 GLI3 NCOA1 RHOXF1 CREBBP EP300 MSGN1 RAD23B | 1.00e-04 | 1459 | 61 | 14 | GO:0000977 |
| GeneOntologyMolecularFunction | histone H3K4 monomethyltransferase activity | 2.54e-04 | 8 | 61 | 2 | GO:0140945 | |
| GeneOntologyMolecularFunction | acetyltransferase activity | 2.88e-04 | 104 | 61 | 4 | GO:0016407 | |
| GeneOntologyMolecularFunction | armadillo repeat domain binding | 3.26e-04 | 9 | 61 | 2 | GO:0070016 | |
| GeneOntologyMolecularFunction | histone H3K4 trimethyltransferase activity | 4.07e-04 | 10 | 61 | 2 | GO:0140999 | |
| GeneOntologyMolecularFunction | beta-catenin binding | 4.97e-04 | 120 | 61 | 4 | GO:0008013 | |
| GeneOntologyMolecularFunction | histone acetyltransferase activity | 5.09e-04 | 51 | 61 | 3 | GO:0004402 | |
| GeneOntologyMolecularFunction | nuclear estrogen receptor binding | 5.70e-04 | 53 | 61 | 3 | GO:0030331 | |
| GeneOntologyMolecularFunction | transcription coactivator binding | 6.02e-04 | 54 | 61 | 3 | GO:0001223 | |
| GeneOntologyMolecularFunction | peptide-lysine-N-acetyltransferase activity | 6.36e-04 | 55 | 61 | 3 | GO:0061733 | |
| GeneOntologyMolecularFunction | nuclear retinoic acid receptor binding | 6.36e-04 | 55 | 61 | 3 | GO:0042974 | |
| GeneOntologyMolecularFunction | peptide N-acetyltransferase activity | 8.20e-04 | 60 | 61 | 3 | GO:0034212 | |
| GeneOntologyMolecularFunction | nuclear receptor coactivator activity | 8.61e-04 | 61 | 61 | 3 | GO:0030374 | |
| GeneOntologyMolecularFunction | histone H3 acetyltransferase activity | 9.40e-04 | 15 | 61 | 2 | GO:0010484 | |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | HEYL POU6F2 TCF7L2 ZNF628 EGR2 ZNF41 ZNF174 GLI3 EP300 MSGN1 RAD23B | 1.23e-03 | 1244 | 61 | 11 | GO:0000978 |
| GeneOntologyMolecularFunction | protein domain specific binding | 1.28e-03 | 875 | 61 | 9 | GO:0019904 | |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | HEYL POU6F2 TCF7L2 ZNF628 EGR2 ZNF41 ZNF174 GLI3 EP300 MSGN1 RAD23B | 1.46e-03 | 1271 | 61 | 11 | GO:0000987 |
| GeneOntologyMolecularFunction | nuclear glucocorticoid receptor binding | 1.68e-03 | 20 | 61 | 2 | GO:0035259 | |
| GeneOntologyMolecularFunction | histone H3K4 methyltransferase activity | 1.68e-03 | 20 | 61 | 2 | GO:0042800 | |
| GeneOntologyMolecularFunction | p53 binding | 1.69e-03 | 77 | 61 | 3 | GO:0002039 | |
| GeneOntologyMolecularFunction | N-acetyltransferase activity | 1.75e-03 | 78 | 61 | 3 | GO:0008080 | |
| GeneOntologyMolecularFunction | damaged DNA binding | 2.17e-03 | 84 | 61 | 3 | GO:0003684 | |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | KMT2C NCOA6 KMT2D TNRC6A NCOA1 GON4L ARID1A SS18 CREBBP EP300 | 2.53e-03 | 1160 | 61 | 10 | GO:0030674 |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | HEYL POU6F2 KMT2D TCF7L2 ZNF628 EGR2 ZNF41 ZNF174 GLI3 RHOXF1 MSGN1 | 3.35e-03 | 1412 | 61 | 11 | GO:0000981 |
| GeneOntologyMolecularFunction | modification-dependent protein binding | 3.63e-03 | 206 | 61 | 4 | GO:0140030 | |
| GeneOntologyMolecularFunction | N-acyltransferase activity | 3.76e-03 | 102 | 61 | 3 | GO:0016410 | |
| GeneOntologyMolecularFunction | nuclear thyroid hormone receptor binding | 4.84e-03 | 34 | 61 | 2 | GO:0046966 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-3,4-bisphosphate binding | 5.12e-03 | 35 | 61 | 2 | GO:0043325 | |
| GeneOntologyMolecularFunction | bHLH transcription factor binding | 5.71e-03 | 37 | 61 | 2 | GO:0043425 | |
| GeneOntologyMolecularFunction | ATP-dependent chromatin remodeler activity | 5.71e-03 | 37 | 61 | 2 | GO:0140658 | |
| GeneOntologyMolecularFunction | acyltransferase activity, transferring groups other than amino-acyl groups | 6.04e-03 | 238 | 61 | 4 | GO:0016747 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 6.91e-03 | 127 | 61 | 3 | GO:0008094 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity, RNA polymerase II-specific | 7.13e-03 | 560 | 61 | 6 | GO:0001228 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity | 7.50e-03 | 566 | 61 | 6 | GO:0001216 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | KMT2C NCOA6 KMT2D TNRC6A NCOA1 GON4L ARID1A SS18 CREBBP EP300 | 7.60e-03 | 1356 | 61 | 10 | GO:0060090 |
| GeneOntologyMolecularFunction | histone H3 methyltransferase activity | 8.00e-03 | 44 | 61 | 2 | GO:0140938 | |
| GeneOntologyMolecularFunction | transcription coregulator binding | 9.03e-03 | 140 | 61 | 3 | GO:0001221 | |
| GeneOntologyMolecularFunction | acyltransferase activity | 9.13e-03 | 775 | 61 | 7 | GO:0016746 | |
| GeneOntologyBiologicalProcess | embryo development | NCOA6 KMT2D TCF7L2 ABL2 GLI3 MATR3 MFN2 NCOA1 CHD8 TNRC6C ARID1A CREBBP EP300 RYR2 MSGN1 RAD23B | 2.87e-06 | 1437 | 61 | 16 | GO:0009790 |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | HEYL KMT2C NCOA6 KMT2D TCF7L2 RPS6KA4 EGR2 GLI3 MED25 NCOA1 CHD8 SS18 CREBBP EP300 MSGN1 | 9.20e-06 | 1390 | 61 | 15 | GO:0045944 |
| GeneOntologyBiologicalProcess | chordate embryonic development | NCOA6 KMT2D TCF7L2 ABL2 GLI3 MATR3 MFN2 NCOA1 CHD8 ARID1A EP300 MSGN1 | 1.14e-05 | 906 | 61 | 12 | GO:0043009 |
| GeneOntologyBiologicalProcess | embryo development ending in birth or egg hatching | NCOA6 KMT2D TCF7L2 ABL2 GLI3 MATR3 MFN2 NCOA1 CHD8 ARID1A EP300 MSGN1 | 1.47e-05 | 929 | 61 | 12 | GO:0009792 |
| GeneOntologyBiologicalProcess | N-terminal peptidyl-lysine acetylation | 5.14e-05 | 4 | 61 | 2 | GO:0018076 | |
| GeneOntologyBiologicalProcess | head development | NCOA6 TCF7L2 ABL2 EGR2 GLI3 NCOA1 CHD8 ARID1A CREBBP EP300 WDR47 | 7.01e-05 | 919 | 61 | 11 | GO:0060322 |
| GeneOntologyBiologicalProcess | stem cell population maintenance | 7.07e-05 | 237 | 61 | 6 | GO:0019827 | |
| GeneOntologyBiologicalProcess | maintenance of cell number | 7.94e-05 | 242 | 61 | 6 | GO:0098727 | |
| GeneOntologyBiologicalProcess | hormone-mediated signaling pathway | 8.31e-05 | 244 | 61 | 6 | GO:0009755 | |
| GeneOntologyBiologicalProcess | isoleucine catabolic process | 8.55e-05 | 5 | 61 | 2 | GO:0006550 | |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | RAG2 KMT2C KMT2D RPS6KA4 MED25 NCOA1 CHD8 ARID1A SS18 CREBBP EP300 | 1.47e-04 | 999 | 61 | 11 | GO:0071824 |
| GeneOntologyBiologicalProcess | response to hormone | HEYL NCOA6 GTF2H1 KMT2D ACAT1 EGR2 MFN2 NCOA1 ARID1A MEAK7 EP300 | 2.12e-04 | 1042 | 61 | 11 | GO:0009725 |
| GeneOntologyBiologicalProcess | embryonic morphogenesis | 2.33e-04 | 713 | 61 | 9 | GO:0048598 | |
| GeneOntologyBiologicalProcess | embryonic organ development | 2.36e-04 | 561 | 61 | 8 | GO:0048568 | |
| GeneOntologyBiologicalProcess | isoleucine metabolic process | 2.38e-04 | 8 | 61 | 2 | GO:0006549 | |
| GeneOntologyBiologicalProcess | face morphogenesis | 2.42e-04 | 41 | 61 | 3 | GO:0060325 | |
| GeneOntologyBiologicalProcess | T cell lineage commitment | 2.60e-04 | 42 | 61 | 3 | GO:0002360 | |
| GeneOntologyBiologicalProcess | chromatin organization | RAG2 KMT2C KMT2D RPS6KA4 NCOA1 CHD8 ARID1A SS18 CREBBP EP300 | 2.74e-04 | 896 | 61 | 10 | GO:0006325 |
| GeneOntologyBiologicalProcess | hindgut morphogenesis | 3.06e-04 | 9 | 61 | 2 | GO:0007442 | |
| GeneOntologyBiologicalProcess | chromatin remodeling | 3.09e-04 | 741 | 61 | 9 | GO:0006338 | |
| GeneOntologyBiologicalProcess | nuclear receptor-mediated signaling pathway | 3.27e-04 | 202 | 61 | 5 | GO:0141193 | |
| GeneOntologyBiologicalProcess | in utero embryonic development | 3.54e-04 | 596 | 61 | 8 | GO:0001701 | |
| GeneOntologyBiologicalProcess | positive regulation of protein localization to nucleus | 3.62e-04 | 114 | 61 | 4 | GO:1900182 | |
| GeneOntologyBiologicalProcess | hindgut development | 3.81e-04 | 10 | 61 | 2 | GO:0061525 | |
| GeneOntologyBiologicalProcess | proximal tubule development | 3.81e-04 | 10 | 61 | 2 | GO:0072014 | |
| GeneOntologyBiologicalProcess | head morphogenesis | 3.87e-04 | 48 | 61 | 3 | GO:0060323 | |
| GeneOntologyBiologicalProcess | androgen receptor signaling pathway | 4.63e-04 | 51 | 61 | 3 | GO:0030521 | |
| GeneOntologyBiologicalProcess | regulation of T cell differentiation | 5.46e-04 | 226 | 61 | 5 | GO:0045580 | |
| GeneOntologyBiologicalProcess | DNA-templated transcription initiation | 6.03e-04 | 231 | 61 | 5 | GO:0006352 | |
| GeneOntologyBiologicalProcess | regulation of sarcomere organization | 6.57e-04 | 13 | 61 | 2 | GO:0060297 | |
| GeneOntologyCellularComponent | chromatin | HEYL POU6F2 TCF7L2 EGR2 ZNF174 NCOA1 GON4L RCC1 CHD8 RHOXF1 ARID1A SS18 CREBBP EP300 DDX6 MSGN1 | 4.45e-06 | 1480 | 62 | 16 | GO:0000785 |
| GeneOntologyCellularComponent | MLL3/4 complex | 5.36e-06 | 12 | 62 | 3 | GO:0044666 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | KMT2C NCOA6 GTF2H1 KMT2D TCF7L2 MED25 NCOA1 GON4L CHD8 NUP188 ARID1A SS18 CREBBP CSTF2T RAD23B | 8.67e-06 | 1377 | 62 | 15 | GO:0140513 |
| GeneOntologyCellularComponent | methyltransferase complex | 1.72e-05 | 108 | 62 | 5 | GO:0034708 | |
| GeneOntologyCellularComponent | transcription regulator complex | 6.18e-05 | 596 | 62 | 9 | GO:0005667 | |
| GeneOntologyCellularComponent | histone methyltransferase complex | 7.28e-05 | 75 | 62 | 4 | GO:0035097 | |
| GeneOntologyCellularComponent | npBAF complex | 7.70e-04 | 14 | 62 | 2 | GO:0071564 | |
| GeneOntologyCellularComponent | RNA polymerase II transcription regulator complex | 1.27e-03 | 272 | 62 | 5 | GO:0090575 | |
| HumanPheno | Natal tooth | 2.19e-06 | 38 | 30 | 5 | HP:0000695 | |
| HumanPheno | Advanced eruption of teeth | 5.79e-06 | 46 | 30 | 5 | HP:0006288 | |
| HumanPheno | Toe deformity | 7.11e-06 | 129 | 30 | 7 | HP:0034398 | |
| HumanPheno | Pilomatrixoma | 1.51e-05 | 9 | 30 | 3 | HP:0030434 | |
| HumanPheno | Abnormal subclavian artery morphology | 2.95e-05 | 11 | 30 | 3 | HP:0031251 | |
| HumanPheno | Plantar crease between first and second toes | 3.35e-05 | 2 | 30 | 2 | HP:0008107 | |
| HumanPheno | Aortic isthmus hypoplasia | 3.35e-05 | 2 | 30 | 2 | HP:0034227 | |
| HumanPheno | High axial triradius | 3.35e-05 | 2 | 30 | 2 | HP:0001042 | |
| HumanPheno | Facial grimacing | 5.07e-05 | 13 | 30 | 3 | HP:0000273 | |
| HumanPheno | Overlapping toe | 5.31e-05 | 72 | 30 | 5 | HP:0001845 | |
| HumanPheno | Laryngeal cartilage malformation | 1.00e-04 | 3 | 30 | 2 | HP:0008752 | |
| HumanPheno | Phobia | 1.00e-04 | 3 | 30 | 2 | HP:5200232 | |
| HumanPheno | Agoraphobia | 1.00e-04 | 3 | 30 | 2 | HP:0000756 | |
| HumanPheno | Humoral immunodeficiency | 1.00e-04 | 3 | 30 | 2 | HP:0005363 | |
| HumanPheno | Prominent nasal septum | 1.00e-04 | 3 | 30 | 2 | HP:0005322 | |
| HumanPheno | Radial deviation of thumb terminal phalanx | 1.00e-04 | 3 | 30 | 2 | HP:0005895 | |
| HumanPheno | Supernumerary tooth | 1.18e-04 | 85 | 30 | 5 | HP:0011069 | |
| HumanPheno | Premature thelarche | 1.19e-04 | 17 | 30 | 3 | HP:0010314 | |
| HumanPheno | Skin appendage neoplasm | 1.42e-04 | 18 | 30 | 3 | HP:0012842 | |
| HumanPheno | Broad phalanx of the toes | 1.46e-04 | 47 | 30 | 4 | HP:0010174 | |
| HumanPheno | Trichiasis | 2.00e-04 | 4 | 30 | 2 | HP:0001128 | |
| HumanPheno | Visceral hemangioma | 2.00e-04 | 4 | 30 | 2 | HP:0410266 | |
| HumanPheno | Talon cusp | 2.00e-04 | 4 | 30 | 2 | HP:0011087 | |
| HumanPheno | Foot pain | 2.00e-04 | 4 | 30 | 2 | HP:0025238 | |
| HumanPheno | Widened distal phalanges | 2.00e-04 | 4 | 30 | 2 | HP:0006200 | |
| HumanPheno | Vascular ring | 2.00e-04 | 4 | 30 | 2 | HP:0010775 | |
| HumanPheno | Hepatic hemangioma | 2.00e-04 | 4 | 30 | 2 | HP:0031207 | |
| HumanPheno | Abnormal eyebrow morphology | RAG2 KMT2C KMT2D RTEL1 MED25 CHD8 NUP188 ARID1A CREBBP KRT25 EP300 DDX6 | 2.31e-04 | 674 | 30 | 12 | HP:0000534 |
| HumanPheno | Inguinal hernia | 3.23e-04 | 312 | 30 | 8 | HP:0000023 | |
| HumanPheno | Increased laxity of ankles | 3.32e-04 | 5 | 30 | 2 | HP:0006460 | |
| HumanPheno | Papillary cystadenoma of the epididymis | 3.32e-04 | 5 | 30 | 2 | HP:0009715 | |
| HumanPheno | Supernumerary cusp | 3.32e-04 | 5 | 30 | 2 | HP:0033777 | |
| HumanPheno | Epididymal neoplasm | 3.32e-04 | 5 | 30 | 2 | HP:0030421 | |
| HumanPheno | Broad hallux phalanx | 3.43e-04 | 24 | 30 | 3 | HP:0010059 | |
| HumanPheno | Perimembranous ventricular septal defect | 4.37e-04 | 26 | 30 | 3 | HP:0011682 | |
| HumanPheno | Large foramen magnum | 4.96e-04 | 6 | 30 | 2 | HP:0002700 | |
| HumanPheno | Abnormality of the helix | 5.72e-04 | 183 | 30 | 6 | HP:0000380 | |
| HumanPheno | Short columella | 6.08e-04 | 29 | 30 | 3 | HP:0002000 | |
| HumanPheno | Preaxial foot polydactyly | 6.72e-04 | 30 | 30 | 3 | HP:0001841 | |
| HumanPheno | Deviated nasal septum | 6.91e-04 | 7 | 30 | 2 | HP:0004411 | |
| HumanPheno | Abnormal lateral ventricle morphology | 8.26e-04 | 129 | 30 | 5 | HP:0030047 | |
| MousePheno | embryonic lethality during organogenesis | NCOA6 KMT2D RTEL1 GLI3 TNRC6A MFN2 CHD8 ARID1A CREBBP EP300 RYR2 DDX6 MSGN1 | 1.69e-05 | 876 | 53 | 13 | MP:0006207 |
| MousePheno | abnormal epicardium morphology | 3.37e-05 | 17 | 53 | 3 | MP:0003057 | |
| MousePheno | embryonic lethality during organogenesis, complete penetrance | NCOA6 KMT2D RTEL1 TNRC6A CHD8 ARID1A CREBBP EP300 RYR2 DDX6 MSGN1 | 5.09e-05 | 700 | 53 | 11 | MP:0011098 |
| MousePheno | abnormal pulmonary valve cusp morphology | 1.12e-04 | 25 | 53 | 3 | MP:0010602 | |
| MousePheno | embryonic lethality, incomplete penetrance | 1.43e-04 | 410 | 53 | 8 | MP:0011102 | |
| MousePheno | prenatal lethality prior to heart atrial septation, incomplete penetrance | 1.43e-04 | 410 | 53 | 8 | MP:0031660 | |
| MousePheno | abnormal grooming behavior | 1.65e-04 | 137 | 53 | 5 | MP:0001440 | |
| MousePheno | increased grooming behavior | 1.74e-04 | 74 | 53 | 4 | MP:0001441 | |
| MousePheno | abnormal intestinal epithelium morphology | 1.83e-04 | 75 | 53 | 4 | MP:0000488 | |
| MousePheno | abnormal pericardium morphology | 1.99e-04 | 225 | 53 | 6 | MP:0000288 | |
| MousePheno | abnormal neuropore morphology | 2.03e-04 | 77 | 53 | 4 | MP:0012542 | |
| MousePheno | enlarged frontal bone | 2.93e-04 | 7 | 53 | 2 | MP:0004375 | |
| MousePheno | abnormal neural tube morphology | 3.40e-04 | 591 | 53 | 9 | MP:0002151 | |
| MousePheno | abnormal germ layer morphology | 3.50e-04 | 161 | 53 | 5 | MP:0014138 | |
| MousePheno | perimembraneous ventricular septal defect | 4.02e-04 | 92 | 53 | 4 | MP:0010418 | |
| MousePheno | abnormal interventricular septum membranous part morphology | 4.19e-04 | 93 | 53 | 4 | MP:0008823 | |
| Domain | Nuc_rcpt_coact | 6.92e-07 | 6 | 62 | 3 | IPR009110 | |
| Domain | Nuc_rcpt_coact_CREBbp | 1.08e-05 | 2 | 62 | 2 | IPR014744 | |
| Domain | HAT_KAT11 | 1.08e-05 | 2 | 62 | 2 | PF08214 | |
| Domain | KIX | 1.08e-05 | 2 | 62 | 2 | PS50952 | |
| Domain | ZnF_TAZ | 1.08e-05 | 2 | 62 | 2 | SM00551 | |
| Domain | M_domain | 1.08e-05 | 2 | 62 | 2 | PF12938 | |
| Domain | CBP_P300_HAT | 1.08e-05 | 2 | 62 | 2 | IPR031162 | |
| Domain | DUF902 | 1.08e-05 | 2 | 62 | 2 | PF06001 | |
| Domain | GW182_M_dom | 1.08e-05 | 2 | 62 | 2 | IPR026805 | |
| Domain | - | 1.08e-05 | 2 | 62 | 2 | 1.20.1020.10 | |
| Domain | RING_CBP-p300 | 1.08e-05 | 2 | 62 | 2 | IPR010303 | |
| Domain | - | 1.08e-05 | 2 | 62 | 2 | 1.10.1630.10 | |
| Domain | Creb_binding | 1.08e-05 | 2 | 62 | 2 | PF09030 | |
| Domain | - | 1.08e-05 | 2 | 62 | 2 | 1.10.246.20 | |
| Domain | zf-TAZ | 1.08e-05 | 2 | 62 | 2 | PF02135 | |
| Domain | ZF_TAZ | 1.08e-05 | 2 | 62 | 2 | PS50134 | |
| Domain | Histone_AcTrfase_Rtt109/CBP | 1.08e-05 | 2 | 62 | 2 | IPR013178 | |
| Domain | KAT11 | 1.08e-05 | 2 | 62 | 2 | SM01250 | |
| Domain | Znf_TAZ | 1.08e-05 | 2 | 62 | 2 | IPR000197 | |
| Domain | KIX_dom | 1.08e-05 | 2 | 62 | 2 | IPR003101 | |
| Domain | KIX | 1.08e-05 | 2 | 62 | 2 | PF02172 | |
| Domain | CBP_P300_HAT | 1.08e-05 | 2 | 62 | 2 | PS51727 | |
| Domain | Ago_hook | 3.25e-05 | 3 | 62 | 2 | PF10427 | |
| Domain | TNRC6_PABC-bd | 3.25e-05 | 3 | 62 | 2 | IPR032226 | |
| Domain | Argonaute_hook_dom | 3.25e-05 | 3 | 62 | 2 | IPR019486 | |
| Domain | TNRC6-PABC_bdg | 3.25e-05 | 3 | 62 | 2 | PF16608 | |
| Domain | FYrich_C | 1.08e-04 | 5 | 62 | 2 | IPR003889 | |
| Domain | FYrich_N | 1.08e-04 | 5 | 62 | 2 | IPR003888 | |
| Domain | FYRC | 1.08e-04 | 5 | 62 | 2 | SM00542 | |
| Domain | FYRN | 1.08e-04 | 5 | 62 | 2 | SM00541 | |
| Domain | FYRN | 1.08e-04 | 5 | 62 | 2 | PF05964 | |
| Domain | FYRC | 1.08e-04 | 5 | 62 | 2 | PF05965 | |
| Domain | FYRC | 1.08e-04 | 5 | 62 | 2 | PS51543 | |
| Domain | FYRN | 1.08e-04 | 5 | 62 | 2 | PS51542 | |
| Domain | Keratin_I | 4.19e-04 | 44 | 62 | 3 | IPR002957 | |
| Domain | HMG_box | 7.25e-04 | 53 | 62 | 3 | PF00505 | |
| Domain | HMG | 7.66e-04 | 54 | 62 | 3 | SM00398 | |
| Domain | UBA-like | 1.26e-03 | 64 | 62 | 3 | IPR009060 | |
| Domain | Post-SET_dom | 1.26e-03 | 16 | 62 | 2 | IPR003616 | |
| Domain | PostSET | 1.26e-03 | 16 | 62 | 2 | SM00508 | |
| Domain | POST_SET | 1.26e-03 | 16 | 62 | 2 | PS50868 | |
| Domain | HMG_box_dom | 1.31e-03 | 65 | 62 | 3 | IPR009071 | |
| Domain | ZZ | 1.60e-03 | 18 | 62 | 2 | PF00569 | |
| Domain | ZF_ZZ_2 | 1.60e-03 | 18 | 62 | 2 | PS50135 | |
| Domain | ZF_ZZ_1 | 1.60e-03 | 18 | 62 | 2 | PS01357 | |
| Domain | Filament | 1.70e-03 | 71 | 62 | 3 | SM01391 | |
| Domain | IF | 1.77e-03 | 72 | 62 | 3 | PS00226 | |
| Domain | Znf_ZZ | 1.79e-03 | 19 | 62 | 2 | IPR000433 | |
| Domain | ZnF_ZZ | 1.79e-03 | 19 | 62 | 2 | SM00291 | |
| Domain | Filament | 1.84e-03 | 73 | 62 | 3 | PF00038 | |
| Domain | RCC1 | 1.98e-03 | 20 | 62 | 2 | PF00415 | |
| Domain | IF | 2.06e-03 | 76 | 62 | 3 | IPR001664 | |
| Domain | RCC1_1 | 2.19e-03 | 21 | 62 | 2 | PS00625 | |
| Domain | RCC1_2 | 2.19e-03 | 21 | 62 | 2 | PS00626 | |
| Domain | RCC1_3 | 2.19e-03 | 21 | 62 | 2 | PS50012 | |
| Domain | EPHD | 2.40e-03 | 22 | 62 | 2 | PS51805 | |
| Domain | Reg_chr_condens | 2.40e-03 | 22 | 62 | 2 | IPR000408 | |
| Domain | - | 2.40e-03 | 22 | 62 | 2 | 2.130.10.30 | |
| Domain | RCC1/BLIP-II | 2.62e-03 | 23 | 62 | 2 | IPR009091 | |
| Domain | Bromodomain_CS | 3.35e-03 | 26 | 62 | 2 | IPR018359 | |
| Domain | ZF_PHD_2 | 3.88e-03 | 95 | 62 | 3 | PS50016 | |
| Domain | ZF_PHD_1 | 4.00e-03 | 96 | 62 | 3 | PS01359 | |
| Domain | UBA | 4.44e-03 | 30 | 62 | 2 | SM00165 | |
| Domain | PAS | 5.04e-03 | 32 | 62 | 2 | SM00091 | |
| Domain | PAS | 5.68e-03 | 34 | 62 | 2 | IPR000014 | |
| Domain | PAS | 5.68e-03 | 34 | 62 | 2 | PS50112 | |
| Domain | - | 5.70e-03 | 109 | 62 | 3 | 4.10.280.10 | |
| Domain | RRM | 5.84e-03 | 217 | 62 | 4 | SM00360 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | KMT2C KRT26 NCOA6 COL9A2 KMT2D TCF7L2 RPS6KA4 ABL2 EGR2 KRT27 TNRC6A MED25 NCOA1 TNRC6C ARID1A SS18 CREBBP KRT25 EP300 MSGN1 | 2.84e-08 | 1432 | 50 | 20 | M509 |
| Pathway | REACTOME_RORA_ACTIVATES_GENE_EXPRESSION | 4.13e-07 | 18 | 50 | 4 | M26942 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION | 4.81e-07 | 84 | 50 | 6 | M1008 | |
| Pathway | BIOCARTA_VDR_PATHWAY | 1.41e-06 | 24 | 50 | 4 | M13404 | |
| Pathway | BIOCARTA_PPARG_PATHWAY | 2.32e-06 | 8 | 50 | 3 | M22058 | |
| Pathway | REACTOME_ADIPOGENESIS | 2.37e-06 | 110 | 50 | 6 | M48259 | |
| Pathway | REACTOME_ACTIVATION_OF_ANTERIOR_HOX_GENES_IN_HINDBRAIN_DEVELOPMENT_DURING_EARLY_EMBRYOGENESIS | 4.32e-06 | 122 | 50 | 6 | M29689 | |
| Pathway | REACTOME_MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT | 8.44e-06 | 137 | 50 | 6 | M48232 | |
| Pathway | REACTOME_NR1H3_NR1H2_REGULATE_GENE_EXPRESSION_LINKED_TO_CHOLESTEROL_TRANSPORT_AND_EFFLUX | 8.48e-06 | 37 | 50 | 4 | M29790 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX1 | 1.88e-05 | 237 | 50 | 7 | M27786 | |
| Pathway | REACTOME_MITF_M_DEPENDENT_GENE_EXPRESSION | 2.08e-05 | 95 | 50 | 5 | M48268 | |
| Pathway | REACTOME_RUNX1_REGULATES_GENES_INVOLVED_IN_MEGAKARYOCYTE_DIFFERENTIATION_AND_PLATELET_FUNCTION | 2.19e-05 | 96 | 50 | 5 | M27792 | |
| Pathway | REACTOME_NR1H2_AND_NR1H3_MEDIATED_SIGNALING | 2.23e-05 | 47 | 50 | 4 | M29777 | |
| Pathway | REACTOME_HEME_SIGNALING | 2.64e-05 | 49 | 50 | 4 | M41832 | |
| Pathway | REACTOME_EPIGENETIC_REGULATION_OF_GENE_EXPRESSION | 2.93e-05 | 254 | 50 | 7 | M27131 | |
| Pathway | REACTOME_REGULATION_OF_CHOLESTEROL_BIOSYNTHESIS_BY_SREBP_SREBF | 4.18e-05 | 55 | 50 | 4 | M27001 | |
| Pathway | REACTOME_REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA | 5.92e-05 | 118 | 50 | 5 | M27316 | |
| Pathway | BIOCARTA_VDR_PATHWAY | 6.17e-05 | 22 | 50 | 3 | MM1370 | |
| Pathway | WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA | 8.08e-05 | 65 | 50 | 4 | M39682 | |
| Pathway | REACTOME_NOTCH3_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 9.14e-05 | 25 | 50 | 3 | M27880 | |
| Pathway | REACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX | 1.03e-04 | 26 | 50 | 3 | MM14793 | |
| Pathway | REACTOME_CIRCADIAN_CLOCK | 1.08e-04 | 70 | 50 | 4 | M938 | |
| Pathway | REACTOME_BMAL1_CLOCK_NPAS2_ACTIVATES_CIRCADIAN_GENE_EXPRESSION | 1.16e-04 | 27 | 50 | 3 | M26943 | |
| Pathway | BIOCARTA_PELP1_PATHWAY | 1.22e-04 | 5 | 50 | 2 | MM1575 | |
| Pathway | REACTOME_NFE2L2_REGULATING_INFLAMMATION_ASSOCIATED_GENES | 1.22e-04 | 5 | 50 | 2 | M48020 | |
| Pathway | REACTOME_NFE2L2_REGULATING_ER_STRESS_ASSOCIATED_GENES | 1.22e-04 | 5 | 50 | 2 | M48023 | |
| Pathway | REACTOME_LRR_FLII_INTERACTING_PROTEIN_1_LRRFIP1_ACTIVATES_TYPE_I_IFN_PRODUCTION | 1.22e-04 | 5 | 50 | 2 | M27228 | |
| Pathway | REACTOME_TGFBR3_EXPRESSION | 1.29e-04 | 28 | 50 | 3 | M48253 | |
| Pathway | WP_KLEEFSTRA_SYNDROME | 1.44e-04 | 29 | 50 | 3 | M48076 | |
| Pathway | REACTOME_SIGNALING_BY_WNT | 1.52e-04 | 330 | 50 | 7 | M7847 | |
| Pathway | PID_RETINOIC_ACID_PATHWAY | 1.59e-04 | 30 | 50 | 3 | M207 | |
| Pathway | REACTOME_ESTROGEN_DEPENDENT_GENE_EXPRESSION | 1.78e-04 | 149 | 50 | 5 | M27888 | |
| Pathway | BIOCARTA_PELP1_PATHWAY | 1.83e-04 | 6 | 50 | 2 | M22062 | |
| Pathway | REACTOME_REGULATION_OF_HOMOTYPIC_CELL_CELL_ADHESION | 1.94e-04 | 32 | 50 | 3 | M48012 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_NPAS4 | 2.33e-04 | 34 | 50 | 3 | M46422 | |
| Pathway | BIOCARTA_PPARG_PATHWAY | 2.56e-04 | 7 | 50 | 2 | MM1573 | |
| Pathway | REACTOME_POST_TRANSCRIPTIONAL_SILENCING_BY_SMALL_RNAS | 2.56e-04 | 7 | 50 | 2 | M46421 | |
| Pathway | REACTOME_METABOLISM_OF_LIPIDS | NCOA6 MBTPS1 ACAT1 ACBD5 MED25 NCOA1 PLEKHA2 GLB1L2 CREBBP EP300 | 2.73e-04 | 757 | 50 | 10 | M27451 |
| Pathway | REACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX | 2.98e-04 | 91 | 50 | 4 | M27101 | |
| Pathway | REACTOME_NFE2L2_REGULATING_MDR_ASSOCIATED_ENZYMES | 3.41e-04 | 8 | 50 | 2 | M48022 | |
| Pathway | REACTOME_REGULATION_OF_NFE2L2_GENE_EXPRESSION | 3.41e-04 | 8 | 50 | 2 | M48024 | |
| Pathway | REACTOME_NFE2L2_REGULATES_PENTOSE_PHOSPHATE_PATHWAY_GENES | 3.41e-04 | 8 | 50 | 2 | M46443 | |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | 3.81e-04 | 272 | 50 | 6 | M29619 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_VENTX | 4.07e-04 | 41 | 50 | 3 | M29748 | |
| Pathway | REACTOME_REGULATION_OF_PTEN_MRNA_TRANSLATION | 4.37e-04 | 9 | 50 | 2 | M27810 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TLR3_IRF3_SIGNALING_PATHWAY | 4.37e-04 | 9 | 50 | 2 | M47451 | |
| Pathway | REACTOME_REGULATION_OF_NPAS4_MRNA_TRANSLATION | 4.37e-04 | 9 | 50 | 2 | M46436 | |
| Pathway | REACTOME_FORMATION_OF_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES | 4.37e-04 | 42 | 50 | 3 | M48018 | |
| Pathway | REACTOME_ACTIVATION_OF_GENE_EXPRESSION_BY_SREBF_SREBP | 4.37e-04 | 42 | 50 | 3 | M27172 | |
| Pathway | REACTOME_DEACTIVATION_OF_THE_BETA_CATENIN_TRANSACTIVATING_COMPLEX | 4.37e-04 | 42 | 50 | 3 | M27272 | |
| Pathway | REACTOME_SUMOYLATION_OF_TRANSCRIPTION_COFACTORS | 5.02e-04 | 44 | 50 | 3 | M27295 | |
| Pathway | REACTOME_REGULATION_OF_CDH11_MRNA_TRANSLATION_BY_MICRORNAS | 5.45e-04 | 10 | 50 | 2 | M48013 | |
| Pathway | REACTOME_REGULATION_OF_FOXO_TRANSCRIPTIONAL_ACTIVITY_BY_ACETYLATION | 5.45e-04 | 10 | 50 | 2 | M27945 | |
| Pathway | PID_HES_HEY_PATHWAY | 6.49e-04 | 48 | 50 | 3 | M288 | |
| Pathway | REACTOME_NOTCH1_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 6.49e-04 | 48 | 50 | 3 | M611 | |
| Pathway | BIOCARTA_CARM1_PATHWAY | 6.64e-04 | 11 | 50 | 2 | MM1521 | |
| Pathway | REACTOME_NFE2L2_REGULATING_TUMORIGENIC_GENES | 6.64e-04 | 11 | 50 | 2 | M48021 | |
| Pathway | REACTOME_REGULATION_OF_GENE_EXPRESSION_BY_HYPOXIA_INDUCIBLE_FACTOR | 6.64e-04 | 11 | 50 | 2 | M26924 | |
| Pathway | REACTOME_SIGNALING_BY_TGFBR3 | 6.90e-04 | 49 | 50 | 3 | M48250 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH3 | 6.90e-04 | 49 | 50 | 3 | M618 | |
| Pathway | BIOCARTA_CARM1_PATHWAY | 7.95e-04 | 12 | 50 | 2 | M7968 | |
| Pathway | REACTOME_ACTIVATION_OF_THE_TFAP2_AP_2_FAMILY_OF_TRANSCRIPTION_FACTORS | 7.95e-04 | 12 | 50 | 2 | M27765 | |
| Pathway | BIOCARTA_PPARA_PATHWAY | 8.21e-04 | 52 | 50 | 3 | M2404 | |
| Pathway | REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING | 8.24e-04 | 119 | 50 | 4 | M607 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION | KMT2C GTF2H1 KMT2D TCF7L2 ZNF41 GLI3 TNRC6A MED25 TNRC6C ARID1A CREBBP EP300 CSTF2T | 8.42e-04 | 1387 | 50 | 13 | M734 |
| Pathway | PID_AR_TF_PATHWAY | 8.68e-04 | 53 | 50 | 3 | M151 | |
| Pathway | REACTOME_REGULATION_OF_NPAS4_GENE_EXPRESSION | 9.38e-04 | 13 | 50 | 2 | M46434 | |
| Pathway | REACTOME_NR1H2_AND_NR1H3_MEDIATED_SIGNALING | 9.38e-04 | 13 | 50 | 2 | MM15622 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_ACTIVATION_OF_MITOCHONDRIAL_BIOGENESIS | 9.67e-04 | 55 | 50 | 3 | M27145 | |
| Pathway | REACTOME_ESR_MEDIATED_SIGNALING | 1.06e-03 | 220 | 50 | 5 | M27794 | |
| Pathway | REACTOME_RUNX3_REGULATES_NOTCH_SIGNALING | 1.09e-03 | 14 | 50 | 2 | M27808 | |
| Pathway | REACTOME_GASTRULATION | 1.11e-03 | 129 | 50 | 4 | M46433 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1_PEST_DOMAIN_MUTANTS_IN_CANCER | 1.13e-03 | 58 | 50 | 3 | M29616 | |
| Pathway | REACTOME_ADHERENS_JUNCTIONS_INTERACTIONS | 1.13e-03 | 58 | 50 | 3 | M11980 | |
| Pathway | REACTOME_CYTOPROTECTION_BY_HMOX1 | 1.25e-03 | 60 | 50 | 3 | M41830 | |
| Pathway | BIOCARTA_RELA_PATHWAY | 1.26e-03 | 15 | 50 | 2 | MM1339 | |
| Pathway | BIOCARTA_RELA_PATHWAY | 1.26e-03 | 15 | 50 | 2 | M10183 | |
| Pathway | BIOCARTA_PITX2_PATHWAY | 1.26e-03 | 15 | 50 | 2 | MM1439 | |
| Pathway | REACTOME_TRAF3_DEPENDENT_IRF_ACTIVATION_PATHWAY | 1.26e-03 | 15 | 50 | 2 | M953 | |
| Pathway | REACTOME_TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT | 1.37e-03 | 233 | 50 | 5 | M27099 | |
| Pathway | REACTOME_CA2_PATHWAY | 1.37e-03 | 62 | 50 | 3 | M27321 | |
| Pathway | REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_LATE_STAGE_BRANCHING_MORPHOGENESIS_PANCREATIC_BUD_PRECURSOR_CELLS | 1.43e-03 | 16 | 50 | 2 | M27121 | |
| Pathway | BIOCARTA_IL7_PATHWAY | 1.43e-03 | 16 | 50 | 2 | M1296 | |
| Pathway | BIOCARTA_IL7_PATHWAY | 1.43e-03 | 16 | 50 | 2 | MM1420 | |
| Pathway | BIOCARTA_PITX2_PATHWAY | 1.43e-03 | 16 | 50 | 2 | M8516 | |
| Pathway | REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_CELL_DEATH_GENES | 1.43e-03 | 16 | 50 | 2 | M27940 | |
| Pathway | REACTOME_REGULATION_OF_RUNX1_EXPRESSION_AND_ACTIVITY | 1.62e-03 | 17 | 50 | 2 | M27788 | |
| Pathway | BIOCARTA_TGFB_PATHWAY | 1.62e-03 | 17 | 50 | 2 | MM1509 | |
| Pathway | REACTOME_ZYGOTIC_GENOME_ACTIVATION_ZGA | 1.62e-03 | 17 | 50 | 2 | M48025 | |
| Pathway | PID_HIF1_TFPATHWAY | 1.64e-03 | 66 | 50 | 3 | M255 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH | 1.74e-03 | 246 | 50 | 5 | M10189 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GLOBAL_GENOME_NER | 1.82e-03 | 18 | 50 | 2 | M47821 | |
| Pathway | REACTOME_FORMATION_OF_PARAXIAL_MESODERM | 1.87e-03 | 69 | 50 | 3 | M46439 | |
| Pathway | KEGG_WNT_SIGNALING_PATHWAY | 1.99e-03 | 151 | 50 | 4 | M19428 | |
| Pathway | REACTOME_REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_APOPTOSIS | 2.03e-03 | 19 | 50 | 2 | M48238 | |
| Pathway | BIOCARTA_TGFB_PATHWAY | 2.03e-03 | 19 | 50 | 2 | M18933 | |
| Pathway | REACTOME_NFE2L2_REGULATING_ANTI_OXIDANT_DETOXIFICATION_ENZYMES | 2.03e-03 | 19 | 50 | 2 | M46442 | |
| Pathway | REACTOME_METABOLISM_OF_STEROIDS | 2.13e-03 | 154 | 50 | 4 | M27832 | |
| Pathway | KEGG_ADHERENS_JUNCTION | 2.19e-03 | 73 | 50 | 3 | M638 | |
| Pathway | REACTOME_NOTCH4_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 2.25e-03 | 20 | 50 | 2 | M27881 | |
| Pubmed | 1.04e-11 | 4 | 64 | 4 | 28398509 | ||
| Pubmed | 3.56e-11 | 14 | 64 | 5 | 12482968 | ||
| Pubmed | CYLD KMT2C NCOA6 KMT2D TCF7L2 GLI3 MATR3 TNRC6A NCOA1 GON4L CHD8 TNRC6C ARID1A SS18 CREBBP RCC2 EP300 | 5.45e-10 | 1429 | 64 | 17 | 35140242 | |
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | KMT2C NCOA6 KMT2D TCF7L2 ACAT1 MATR3 TNRC6A NUP188 ARID1A CREBBP EP300 | 7.11e-10 | 457 | 64 | 11 | 32344865 |
| Pubmed | Interaction network of human early embryonic transcription factors. | KMT2C NCOA6 KMT2D TCF7L2 EGR2 NCOA1 CHD8 ARID1A CREBBP EP300 | 9.01e-10 | 351 | 64 | 10 | 38297188 |
| Pubmed | KMT2C NCOA6 KMT2D TCF7L2 ZNF174 NCOA1 RCC1 CHD8 ARID1A CREBBP RCC2 EP300 CSTF2T DDX6 RAD23B | 1.12e-09 | 1103 | 64 | 15 | 34189442 | |
| Pubmed | KMT2C NCOA6 GAPVD1 KMT2D MATR3 RCC1 CHD8 ARID1A CREBBP EP300 CSTF2T | 4.80e-09 | 549 | 64 | 11 | 38280479 | |
| Pubmed | 5.10e-09 | 12 | 64 | 4 | 12189208 | ||
| Pubmed | 5.94e-09 | 3 | 64 | 3 | 16874310 | ||
| Pubmed | 7.07e-09 | 78 | 64 | 6 | 28611094 | ||
| Pubmed | MED25 is distinct from TRAP220/MED1 in cooperating with CBP for retinoid receptor activation. | 1.03e-08 | 14 | 64 | 4 | 17641689 | |
| Pubmed | 1.67e-08 | 157 | 64 | 7 | 30186101 | ||
| Pubmed | 2.37e-08 | 4 | 64 | 3 | 34645806 | ||
| Pubmed | 2.37e-08 | 4 | 64 | 3 | 12208951 | ||
| Pubmed | 2.37e-08 | 4 | 64 | 3 | 11463834 | ||
| Pubmed | 2.37e-08 | 4 | 64 | 3 | 11113179 | ||
| Pubmed | 4.94e-08 | 20 | 64 | 4 | 11877444 | ||
| Pubmed | 5.93e-08 | 5 | 64 | 3 | 21670263 | ||
| Pubmed | 5.93e-08 | 5 | 64 | 3 | 14722092 | ||
| Pubmed | 5.93e-08 | 5 | 64 | 3 | 11912212 | ||
| Pubmed | 6.09e-08 | 21 | 64 | 4 | 19596656 | ||
| Pubmed | 7.00e-08 | 57 | 64 | 5 | 18022353 | ||
| Pubmed | Temporal/spatial expression of nuclear receptor coactivators in the mouse lung. | 1.18e-07 | 6 | 64 | 3 | 11076796 | |
| Pubmed | Role of CBP in regulating HIF-1-mediated activation of transcription. | 1.18e-07 | 6 | 64 | 3 | 15615775 | |
| Pubmed | 1.18e-07 | 6 | 64 | 3 | 12408825 | ||
| Pubmed | 1.18e-07 | 6 | 64 | 3 | 10973497 | ||
| Pubmed | 1.18e-07 | 6 | 64 | 3 | 10497212 | ||
| Pubmed | Coactivator as a target gene specificity determinant for histone H3 lysine 4 methyltransferases. | 1.18e-07 | 6 | 64 | 3 | 17021013 | |
| Pubmed | 1.76e-07 | 332 | 64 | 8 | 37433992 | ||
| Pubmed | Chromatin remodelling by the glucocorticoid receptor requires the BRG1 complex. | 2.07e-07 | 7 | 64 | 3 | 9590696 | |
| Pubmed | 2.07e-07 | 7 | 64 | 3 | 19556342 | ||
| Pubmed | 3.31e-07 | 8 | 64 | 3 | 24768540 | ||
| Pubmed | 3.31e-07 | 8 | 64 | 3 | 17475621 | ||
| Pubmed | ZMYM3 regulates BRCA1 localization at damaged chromatin to promote DNA repair. | 3.55e-07 | 150 | 64 | 6 | 28242625 | |
| Pubmed | 4.68e-07 | 83 | 64 | 5 | 28794006 | ||
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | 6.94e-07 | 398 | 64 | 8 | 35016035 | |
| Pubmed | Natural helix 9 mutants of PPARγ differently affect its transcriptional activity. | 7.07e-07 | 10 | 64 | 3 | 30595551 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | HEYL KMT2C NCOA6 KMT2D ZNF628 MFN2 CHD8 NUP188 TNRC6C ARID1A D2HGDH EP300 | 7.14e-07 | 1105 | 64 | 12 | 35748872 |
| Pubmed | A census of human transcription factors: function, expression and evolution. | HEYL POU6F2 KMT2D TCF7L2 EGR2 ZNF174 GLI3 NCOA1 GON4L RHOXF1 MSGN1 | 7.61e-07 | 908 | 64 | 11 | 19274049 |
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | GAPVD1 GTF2H1 RPS6KA4 ABL2 RCC1 NUP188 CREBBP RCC2 EP300 DDX6 RAD23B | 7.78e-07 | 910 | 64 | 11 | 36736316 |
| Pubmed | 9.70e-07 | 11 | 64 | 3 | 10454579 | ||
| Pubmed | Corepressors selectively control the transcriptional activity of PPARgamma in adipocytes. | 9.70e-07 | 11 | 64 | 3 | 15681609 | |
| Pubmed | Enhancer Activity Requires CBP/P300 Bromodomain-Dependent Histone H3K27 Acetylation. | 1.03e-06 | 180 | 64 | 6 | 30110629 | |
| Pubmed | 1.29e-06 | 12 | 64 | 3 | 15617563 | ||
| Pubmed | 1.37e-06 | 103 | 64 | 5 | 10819331 | ||
| Pubmed | 1.68e-06 | 13 | 64 | 3 | 19524524 | ||
| Pubmed | Demethylation of H3K27 regulates polycomb recruitment and H2A ubiquitination. | 1.68e-06 | 13 | 64 | 3 | 17761849 | |
| Pubmed | 1.85e-06 | 199 | 64 | 6 | 36688959 | ||
| Pubmed | 2.49e-06 | 638 | 64 | 9 | 31182584 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | PLEKHH1 EP400P1 KMT2C MBTPS1 POU6F2 TCF7L2 RTEL1 PLEKHA2 IQCN TNRC6C ARID1A CREBBP EP300 | 2.64e-06 | 1489 | 64 | 13 | 28611215 |
| Pubmed | 2.66e-06 | 15 | 64 | 3 | 10567404 | ||
| Pubmed | 2.66e-06 | 15 | 64 | 3 | 17925232 | ||
| Pubmed | 3.27e-06 | 16 | 64 | 3 | 23870121 | ||
| Pubmed | A human RNA polymerase II complex containing factors that modify chromatin structure. | 3.27e-06 | 16 | 64 | 3 | 9710619 | |
| Pubmed | 3.27e-06 | 16 | 64 | 3 | 24368734 | ||
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | 3.30e-06 | 220 | 64 | 6 | 35785414 | |
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 27881875 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 28483418 | ||
| Pubmed | Molecular characterization of the histone acetyltransferase CREBBP/EP300 genes in myeloid neoplasia. | 3.33e-06 | 2 | 64 | 2 | 34845315 | |
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 19729597 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 15860545 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 29460469 | ||
| Pubmed | Expression of p300 and CBP is associated with poor prognosis in small cell lung cancer. | 3.33e-06 | 2 | 64 | 2 | 24551300 | |
| Pubmed | The MLL3/4 H3K4 methyltransferase complex in establishing an active enhancer landscape. | 3.33e-06 | 2 | 64 | 2 | 34156443 | |
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 33911074 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 9018065 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 24648406 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 30135524 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 39287984 | ||
| Pubmed | Distribution of co-activators CBP and p300 during mouse oocyte and embryo development. | 3.33e-06 | 2 | 64 | 2 | 16596650 | |
| Pubmed | The p300 and CBP Transcriptional Coactivators Are Required for β-Cell and α-Cell Proliferation. | 3.33e-06 | 2 | 64 | 2 | 29217654 | |
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 20717166 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 10049825 | ||
| Pubmed | CBP/p300 acetyltransferase activity in hematologic malignancies. | 3.33e-06 | 2 | 64 | 2 | 27380996 | |
| Pubmed | CREBBP and p300 lysine acetyl transferases in the DNA damage response. | 3.33e-06 | 2 | 64 | 2 | 29170789 | |
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 25893291 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 11559821 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 21555743 | ||
| Pubmed | TCF-4 binds beta-catenin and is expressed in distinct regions of the embryonic brain and limbs. | 3.33e-06 | 2 | 64 | 2 | 9784592 | |
| Pubmed | CBP/p300 induction is required for retinoic acid sensitivity in human mammary cells. | 3.33e-06 | 2 | 64 | 2 | 12646247 | |
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 31924266 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 32576962 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 27280393 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 19822209 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 24522976 | ||
| Pubmed | RNA helicase DDX6 and scaffold protein GW182 in P-bodies promote biogenesis of stress granules. | 3.33e-06 | 2 | 64 | 2 | 37427791 | |
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 11867645 | ||
| Pubmed | CBP is required for environmental enrichment-induced neurogenesis and cognitive enhancement. | 3.33e-06 | 2 | 64 | 2 | 21847097 | |
| Pubmed | Expression of the nuclear coactivators CBP and p300 in developing craniofacial tissue. | 3.33e-06 | 2 | 64 | 2 | 11963968 | |
| Pubmed | p300 or CBP is required for insulin-stimulated glucose uptake in skeletal muscle and adipocytes. | 3.33e-06 | 2 | 64 | 2 | 34813504 | |
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 36869380 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 9528808 | ||
| Pubmed | Analysis of genetic stability at the EP300 and CREBBP loci in a panel of cancer cell lines. | 3.33e-06 | 2 | 64 | 2 | 12696060 | |
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 11030627 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 20301699 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 28967912 | ||
| Pubmed | CBP Is Required for Establishing Adaptive Gene Programs in the Adult Mouse Brain. | 3.33e-06 | 2 | 64 | 2 | 36109165 | |
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 24639469 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 37816914 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 12242694 | ||
| Interaction | ERG interactions | KMT2C NCOA6 KMT2D TCF7L2 MATR3 ARID1A SS18 CREBBP RCC2 EP300 | 1.72e-09 | 223 | 63 | 10 | int:ERG |
| Interaction | GCM1 interactions | 1.73e-09 | 68 | 63 | 7 | int:GCM1 | |
| Interaction | TBXT interactions | 2.81e-09 | 116 | 63 | 8 | int:TBXT | |
| Interaction | EGR2 interactions | 2.95e-09 | 171 | 63 | 9 | int:EGR2 | |
| Interaction | FOS interactions | CYLD KMT2C NCOA6 KMT2D TCF7L2 RPS6KA4 NCOA1 ARID1A SS18 CREBBP EP300 | 3.09e-09 | 312 | 63 | 11 | int:FOS |
| Interaction | SOX7 interactions | 6.55e-09 | 82 | 63 | 7 | int:SOX7 | |
| Interaction | HNF4A interactions | KMT2C NCOA6 GTF2H1 KMT2D TCF7L2 NCOA1 ARID1A SS18 CREBBP EP300 | 1.29e-08 | 275 | 63 | 10 | int:HNF4A |
| Interaction | FOXI1 interactions | 1.47e-08 | 92 | 63 | 7 | int:FOXI1 | |
| Interaction | NCOA6 interactions | 1.64e-08 | 145 | 63 | 8 | int:NCOA6 | |
| Interaction | NUP35 interactions | KMT2C NCOA6 KMT2D TCF7L2 ACAT1 MATR3 TNRC6A NUP188 ARID1A CREBBP EP300 | 7.24e-08 | 424 | 63 | 11 | int:NUP35 |
| Interaction | PAX7 interactions | 1.17e-07 | 124 | 63 | 7 | int:PAX7 | |
| Interaction | MYOD1 interactions | 1.57e-07 | 194 | 63 | 8 | int:MYOD1 | |
| Interaction | KLF5 interactions | 1.63e-07 | 195 | 63 | 8 | int:KLF5 | |
| Interaction | HNF1A interactions | 1.83e-07 | 80 | 63 | 6 | int:HNF1A | |
| Interaction | GATA2 interactions | 1.91e-07 | 199 | 63 | 8 | int:GATA2 | |
| Interaction | RBBP5 interactions | 2.57e-07 | 287 | 63 | 9 | int:RBBP5 | |
| Interaction | AR interactions | KMT2C NCOA6 GTF2H1 KMT2D TCF7L2 ABL2 GLI3 MATR3 NCOA1 CHD8 NUP188 ARID1A CREBBP RCC2 EP300 | 2.88e-07 | 992 | 63 | 15 | int:AR |
| Interaction | TLX3 interactions | 2.88e-07 | 291 | 63 | 9 | int:TLX3 | |
| Interaction | SP7 interactions | 4.16e-07 | 304 | 63 | 9 | int:SP7 | |
| Interaction | PAGR1 interactions | 5.34e-07 | 51 | 63 | 5 | int:PAGR1 | |
| Interaction | SOX9 interactions | 5.79e-07 | 97 | 63 | 6 | int:SOX9 | |
| Interaction | SMG7 interactions | 6.23e-07 | 319 | 63 | 9 | int:SMG7 | |
| Interaction | TPRX2 interactions | 8.58e-07 | 56 | 63 | 5 | int:TPRX2 | |
| Interaction | NR6A1 interactions | 8.79e-07 | 24 | 63 | 4 | int:NR6A1 | |
| Interaction | CEBPA interactions | KMT2C NCOA6 KMT2D TCF7L2 ZNF174 MATR3 NCOA1 RCC1 CHD8 ARID1A CREBBP RCC2 EP300 CSTF2T DDX6 RAD23B | 9.45e-07 | 1245 | 63 | 16 | int:CEBPA |
| Interaction | HDAC1 interactions | MBTPS1 GAPVD1 KMT2D TCF7L2 GLI3 MATR3 TNRC6A GON4L CHD8 HSD17B10 ARID1A SS18 CREBBP EP300 CSTF2T | 1.17e-06 | 1108 | 63 | 15 | int:HDAC1 |
| Interaction | TEAD1 interactions | 1.26e-06 | 176 | 63 | 7 | int:TEAD1 | |
| Interaction | ASH2L interactions | 1.67e-06 | 265 | 63 | 8 | int:ASH2L | |
| Interaction | HNF1B interactions | 2.10e-06 | 190 | 63 | 7 | int:HNF1B | |
| Interaction | ETV4 interactions | 2.45e-06 | 69 | 63 | 5 | int:ETV4 | |
| Interaction | TNRC6A interactions | 2.51e-06 | 280 | 63 | 8 | int:TNRC6A | |
| Interaction | FEV interactions | 3.26e-06 | 203 | 63 | 7 | int:FEV | |
| Interaction | H2AC4 interactions | KMT2C KMT2D GON4L RCC1 CHD8 HSD17B10 ARID1A CREBBP EP300 RAD23B | 3.53e-06 | 506 | 63 | 10 | int:H2AC4 |
| Interaction | CNOT3 interactions | 3.70e-06 | 207 | 63 | 7 | int:CNOT3 | |
| Interaction | E2F5 interactions | 4.74e-06 | 36 | 63 | 4 | int:E2F5 | |
| Interaction | HOXB2 interactions | 4.74e-06 | 36 | 63 | 4 | int:HOXB2 | |
| Interaction | KLF1 interactions | 5.30e-06 | 37 | 63 | 4 | int:KLF1 | |
| Interaction | YTHDF2 interactions | 5.58e-06 | 312 | 63 | 8 | int:YTHDF2 | |
| Interaction | WDR5 interactions | CYLD KMT2C NCOA6 KMT2D ACAT1 EGR2 MATR3 TNRC6A RCC1 CHD8 CREBBP RCC2 EP300 DDX6 | 5.87e-06 | 1101 | 63 | 14 | int:WDR5 |
| Interaction | WWTR1 interactions | 6.19e-06 | 422 | 63 | 9 | int:WWTR1 | |
| Interaction | NCOA1 interactions | 6.31e-06 | 146 | 63 | 6 | int:NCOA1 | |
| Interaction | ELF5 interactions | 6.56e-06 | 147 | 63 | 6 | int:ELF5 | |
| Interaction | IRF4 interactions | 6.87e-06 | 85 | 63 | 5 | int:IRF4 | |
| Interaction | GSC interactions | 7.70e-06 | 87 | 63 | 5 | int:GSC | |
| Interaction | ASCL2 interactions | 8.14e-06 | 13 | 63 | 3 | int:ASCL2 | |
| Interaction | KRT71 interactions | 9.76e-06 | 43 | 63 | 4 | int:KRT71 | |
| Interaction | SMAD3 interactions | 9.82e-06 | 447 | 63 | 9 | int:SMAD3 | |
| Interaction | SOX10 interactions | 1.01e-05 | 92 | 63 | 5 | int:SOX10 | |
| Interaction | SMAD1 interactions | 1.06e-05 | 243 | 63 | 7 | int:SMAD1 | |
| Interaction | SOX17 interactions | 1.19e-05 | 95 | 63 | 5 | int:SOX17 | |
| Interaction | SS18L1 interactions | 1.38e-05 | 98 | 63 | 5 | int:SS18L1 | |
| Interaction | CRX interactions | 1.41e-05 | 254 | 63 | 7 | int:CRX | |
| Interaction | RXRA interactions | 1.46e-05 | 169 | 63 | 6 | int:RXRA | |
| Interaction | KMT2D interactions | 1.46e-05 | 169 | 63 | 6 | int:KMT2D | |
| Interaction | SETD1A interactions | 1.51e-05 | 170 | 63 | 6 | int:SETD1A | |
| Interaction | CREBBP interactions | NCOA6 KMT2D TCF7L2 EGR2 GLI3 MED25 NCOA1 ARID1A CREBBP EP300 | 1.54e-05 | 599 | 63 | 10 | int:CREBBP |
| Interaction | TLX1 interactions | 1.77e-05 | 175 | 63 | 6 | int:TLX1 | |
| Interaction | EP300 interactions | NCOA6 GAPVD1 KMT2D TCF7L2 EGR2 HDHD5 MATR3 NCOA1 RCC1 ARID1A SS18 CREBBP RCC2 EP300 DDX6 | 2.02e-05 | 1401 | 63 | 15 | int:EP300 |
| Interaction | TLE3 interactions | 2.16e-05 | 376 | 63 | 8 | int:TLE3 | |
| Interaction | ARID1A interactions | 2.41e-05 | 276 | 63 | 7 | int:ARID1A | |
| Interaction | MEX3A interactions | 2.51e-05 | 384 | 63 | 8 | int:MEX3A | |
| Interaction | PAX8 interactions | 2.52e-05 | 111 | 63 | 5 | int:PAX8 | |
| Interaction | THRA interactions | 2.52e-05 | 111 | 63 | 5 | int:THRA | |
| Interaction | SMAD2 interactions | 2.55e-05 | 385 | 63 | 8 | int:SMAD2 | |
| Interaction | NFIA interactions | 2.66e-05 | 188 | 63 | 6 | int:NFIA | |
| Interaction | TBR1 interactions | 2.75e-05 | 113 | 63 | 5 | int:TBR1 | |
| Interaction | YAP1 interactions | KMT2C NCOA6 GAPVD1 KMT2D MATR3 RCC1 CHD8 ARID1A CREBBP KRT25 EP300 CSTF2T DDX6 | 2.77e-05 | 1095 | 63 | 13 | int:YAP1 |
| Interaction | BCL3 interactions | 2.82e-05 | 56 | 63 | 4 | int:BCL3 | |
| Interaction | PSMC2 interactions | 2.96e-05 | 393 | 63 | 8 | int:PSMC2 | |
| Interaction | TRIM24 interactions | 3.23e-05 | 398 | 63 | 8 | int:TRIM24 | |
| Interaction | RARG interactions | 3.24e-05 | 58 | 63 | 4 | int:RARG | |
| Interaction | KRT72 interactions | 3.47e-05 | 59 | 63 | 4 | int:KRT72 | |
| Interaction | HCFC1 interactions | 3.52e-05 | 293 | 63 | 7 | int:HCFC1 | |
| Interaction | TOP3B interactions | HEYL KMT2C NCOA6 KMT2D ZNF628 RTEL1 MFN2 RCC1 CHD8 NUP188 TNRC6C ARID1A D2HGDH EP300 DDX6 | 3.55e-05 | 1470 | 63 | 15 | int:TOP3B |
| Interaction | H2BC3 interactions | 3.72e-05 | 406 | 63 | 8 | int:H2BC3 | |
| Interaction | ETS1 interactions | 3.82e-05 | 121 | 63 | 5 | int:ETS1 | |
| Interaction | NR3C1 interactions | PLEKHH1 NCOA6 GAPVD1 KMT2D MED25 NCOA1 NUP188 ARID1A SS18 CREBBP EP300 RYR2 | 4.14e-05 | 974 | 63 | 12 | int:NR3C1 |
| Interaction | KRT4 interactions | 4.22e-05 | 62 | 63 | 4 | int:KRT4 | |
| Interaction | DEAF1 interactions | 4.79e-05 | 64 | 63 | 4 | int:DEAF1 | |
| Interaction | UTY interactions | 4.93e-05 | 23 | 63 | 3 | int:UTY | |
| Interaction | PAN3 interactions | 5.09e-05 | 65 | 63 | 4 | int:PAN3 | |
| Interaction | PAX9 interactions | 5.38e-05 | 130 | 63 | 5 | int:PAX9 | |
| Interaction | KMT2B interactions | 5.38e-05 | 130 | 63 | 5 | int:KMT2B | |
| Interaction | KMT2C interactions | 6.22e-05 | 134 | 63 | 5 | int:KMT2C | |
| Interaction | RARA interactions | 6.89e-05 | 223 | 63 | 6 | int:RARA | |
| Interaction | RAD23A interactions | 7.06e-05 | 224 | 63 | 6 | int:RAD23A | |
| Interaction | NCOA2 interactions | 7.92e-05 | 141 | 63 | 5 | int:NCOA2 | |
| Interaction | GPBP1 interactions | 8.92e-05 | 75 | 63 | 4 | int:GPBP1 | |
| Interaction | PSMC6 interactions | 9.33e-05 | 342 | 63 | 7 | int:PSMC6 | |
| Interaction | TCF12 interactions | 9.96e-05 | 148 | 63 | 5 | int:TCF12 | |
| Interaction | SOX2 interactions | KMT2C NCOA6 KMT2D TCF7L2 ACAT1 GLI3 MATR3 TNRC6A CHD8 HSD17B10 ARID1A SS18 EP300 RAD23B | 1.00e-04 | 1422 | 63 | 14 | int:SOX2 |
| Interaction | TOMM20 interactions | 1.03e-04 | 240 | 63 | 6 | int:TOMM20 | |
| Interaction | EIF3D interactions | 1.13e-04 | 244 | 63 | 6 | int:EIF3D | |
| Interaction | ASF1A interactions | 1.26e-04 | 249 | 63 | 6 | int:ASF1A | |
| Interaction | PPARGC1A interactions | 1.26e-04 | 82 | 63 | 4 | int:PPARGC1A | |
| Interaction | IRF1 interactions | 1.32e-04 | 83 | 63 | 4 | int:IRF1 | |
| Interaction | NR1H4 interactions | 1.35e-04 | 32 | 63 | 3 | int:NR1H4 | |
| Interaction | PAX6 interactions | 1.42e-04 | 366 | 63 | 7 | int:PAX6 | |
| Interaction | LGR6 interactions | 1.43e-04 | 6 | 63 | 2 | int:LGR6 | |
| Interaction | KLF4 interactions | 1.44e-04 | 160 | 63 | 5 | int:KLF4 | |
| Cytoband | 17q21.2 | 2.94e-06 | 70 | 64 | 4 | 17q21.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr16q24 | 9.28e-04 | 136 | 64 | 3 | chr16q24 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 8.33e-06 | 17 | 43 | 3 | 486 | |
| GeneFamily | Ataxins|Trinucleotide repeat containing | 2.78e-05 | 25 | 43 | 3 | 775 | |
| GeneFamily | Keratins, type I | 3.94e-05 | 28 | 43 | 3 | 608 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 8.25e-04 | 18 | 43 | 2 | 91 | |
| GeneFamily | EF-hand domain containing|Nucleotide excision repair|Transcription and export complex 2 | 8.25e-04 | 18 | 43 | 2 | 1269 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 2.95e-03 | 34 | 43 | 2 | 487 | |
| GeneFamily | Collagens | 5.35e-03 | 46 | 43 | 2 | 490 | |
| GeneFamily | X-linked mental retardation|Angiotensin receptors | 7.05e-03 | 53 | 43 | 2 | 103 | |
| ToppCell | CV-Mild-6|Mild / Virus stimulation, Condition and Cluster | 5.32e-06 | 175 | 64 | 5 | c4d530dbb37942427c9cd0a1533faeb6a3a45381 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.79e-06 | 184 | 64 | 5 | 5350b58aa9979631228835d11eb45ddf81d08bff | |
| Drug | GSK-3 Inhibitor IX; Down 200; 0.5uM; PC3; HT_HG-U133A | 6.53e-08 | 192 | 64 | 8 | 7106_DN | |
| Drug | Flumethasone [2135-17-3]; Down 200; 9.8uM; MCF7; HT_HG-U133A | 8.61e-08 | 199 | 64 | 8 | 3410_DN | |
| Drug | Estradiol-17 beta [50-28-2]; Down 200; 14.6uM; MCF7; HT_HG-U133A | 1.25e-06 | 195 | 64 | 7 | 5318_DN | |
| Drug | Chloramphenicol [56-75-7]; Down 200; 12.4uM; HL60; HT_HG-U133A | 1.25e-06 | 195 | 64 | 7 | 1837_DN | |
| Drug | Hydrastinine hydrochloride [4884-68-8]; Up 200; 16.4uM; PC3; HT_HG-U133A | 1.34e-06 | 197 | 64 | 7 | 2119_UP | |
| Drug | Clidinium bromide [3485-62-9]; Down 200; 9.2uM; PC3; HT_HG-U133A | 1.34e-06 | 197 | 64 | 7 | 4499_DN | |
| Drug | Nalbuphine hydrochloride [23277-43-2]; Up 200; 10.2uM; PC3; HT_HG-U133A | 1.43e-06 | 199 | 64 | 7 | 5820_UP | |
| Drug | Phenoxybenzamine hydrochloride [63-92-3]; Down 200; 11.8uM; PC3; HT_HG-U133A | 1.05e-05 | 177 | 64 | 6 | 4652_DN | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; PC3; HT_HG-U133A | 1.15e-05 | 180 | 64 | 6 | 4541_DN | |
| Drug | Tolbutamide [64-77-7]; Down 200; 14.8uM; MCF7; HT_HG-U133A | 1.57e-05 | 190 | 64 | 6 | 4362_DN | |
| Drug | Estrone [53-16-7]; Down 200; 14.8uM; PC3; HT_HG-U133A | 1.76e-05 | 194 | 64 | 6 | 6647_DN | |
| Drug | Oxybutynin chloride [1508-65-2]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 1.76e-05 | 194 | 64 | 6 | 3168_DN | |
| Drug | Sulfamethazine sodium salt [1981-58-4]; Down 200; 13.4uM; MCF7; HT_HG-U133A | 1.87e-05 | 196 | 64 | 6 | 3422_DN | |
| Drug | Nomifensine maleate [32795-47-4]; Down 200; 11.2uM; PC3; HT_HG-U133A | 1.87e-05 | 196 | 64 | 6 | 5863_DN | |
| Drug | Fluvastatin sodium salt [93957-55-2]; Down 200; 9.2uM; MCF7; HT_HG-U133A | 1.87e-05 | 196 | 64 | 6 | 5290_DN | |
| Drug | Benserazide hydrochloride [14919-77-8]; Down 200; 13.6uM; MCF7; HT_HG-U133A | 1.92e-05 | 197 | 64 | 6 | 5322_DN | |
| Drug | Chloroquine diphosphate [50-63-5]; Up 200; 7.8uM; MCF7; HT_HG-U133A | 1.92e-05 | 197 | 64 | 6 | 2869_UP | |
| Drug | 4,4'-DBP | 1.99e-05 | 19 | 64 | 3 | CID000007034 | |
| Drug | Dicloxacillin sodium salt [13412-64-1]; Down 200; 8.2uM; MCF7; HT_HG-U133A | 2.03e-05 | 199 | 64 | 6 | 3307_DN | |
| Drug | Sulpiride [15676-16-1]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 2.03e-05 | 199 | 64 | 6 | 1467_DN | |
| Drug | clozapine; Down 200; 10uM; MCF7; HT_HG-U133A | 2.09e-05 | 200 | 64 | 6 | 6947_DN | |
| Drug | 3,4-dimethoxy-N-((2,2-dimethyl-2H-chromen-6-yl)methyl)-N-phenylbenzenesulfonamide | 7.74e-05 | 5 | 64 | 2 | ctd:C575894 | |
| Drug | 2,4-xylidinothiazoline | 8.15e-05 | 30 | 64 | 3 | CID000099296 | |
| Drug | 2-methylacetoacetate | 1.16e-04 | 6 | 64 | 2 | CID000150996 | |
| Drug | androstan-3-ol | 1.16e-04 | 6 | 64 | 2 | ctd:C000658 | |
| Drug | AC1L1COZ | 1.21e-04 | 90 | 64 | 4 | CID000001996 | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 1.30e-04 | 174 | 64 | 5 | 1659_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.41e-04 | 177 | 64 | 5 | 3227_DN | |
| Drug | Prenylamine lactate [69-43-2]; Up 200; 9.6uM; HL60; HG-U133A | 1.69e-04 | 184 | 64 | 5 | 1737_UP | |
| Drug | Monensin sodium salt [22373-78-0]; Up 200; 5.8uM; PC3; HT_HG-U133A | 1.74e-04 | 185 | 64 | 5 | 7402_UP | |
| Drug | 2-propylpentanoic acid; Down 200; 50uM; MCF7; HT_HG-U133A | 2.06e-04 | 192 | 64 | 5 | 1647_DN | |
| Drug | Zaprinast [37762-06-4]; Down 200; 14.8uM; PC3; HT_HG-U133A | 2.11e-04 | 193 | 64 | 5 | 6749_DN | |
| Drug | thioridazine hydrochloride; Up 200; 10uM; HL60; HT_HG-U133A | 2.11e-04 | 193 | 64 | 5 | 6189_UP | |
| Drug | Pramoxine hydrochloride [637-58-1]; Up 200; 12.2uM; PC3; HT_HG-U133A | 2.11e-04 | 193 | 64 | 5 | 3811_UP | |
| Drug | Piperine [94-62-2]; Down 200; 14uM; MCF7; HT_HG-U133A | 2.11e-04 | 193 | 64 | 5 | 3263_DN | |
| Drug | Flucytosine [2022-85-7]; Down 200; 31uM; MCF7; HT_HG-U133A | 2.11e-04 | 193 | 64 | 5 | 5289_DN | |
| Drug | Glycocholic acid [475-31-0]; Down 200; 8.6uM; MCF7; HT_HG-U133A | 2.16e-04 | 194 | 64 | 5 | 5316_DN | |
| Drug | Metergoline [17692-51-2]; Up 200; 10uM; HL60; HG-U133A | 2.16e-04 | 194 | 64 | 5 | 1606_UP | |
| Drug | Thonzonium bromide [553-08-2]; Down 200; 6.8uM; PC3; HT_HG-U133A | 2.16e-04 | 194 | 64 | 5 | 4617_DN | |
| Drug | Indomethacin [53-86-1]; Down 200; 11.2uM; PC3; HT_HG-U133A | 2.16e-04 | 194 | 64 | 5 | 5049_DN | |
| Drug | Conessine [546-06-5]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 2.16e-04 | 194 | 64 | 5 | 2792_DN | |
| Drug | Harmol hydrochloride monohydrate [40580-83-4]; Down 200; 15.8uM; MCF7; HT_HG-U133A | 2.16e-04 | 194 | 64 | 5 | 2900_DN | |
| Drug | Fenspiride hydrochloride [5053-08-7]; Down 200; 13.4uM; PC3; HT_HG-U133A | 2.16e-04 | 194 | 64 | 5 | 2106_DN | |
| Drug | 0316684-0000 [391209-55-5]; Down 200; 10uM; PC3; HT_HG-U133A | 2.16e-04 | 194 | 64 | 5 | 7098_DN | |
| Drug | Medrysone [2668-66-8]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 2.16e-04 | 194 | 64 | 5 | 4727_DN | |
| Drug | Halcinonide [3093-35-4]; Down 200; 8.8uM; HL60; HT_HG-U133A | 2.16e-04 | 194 | 64 | 5 | 2185_DN | |
| Drug | Hydrocortisone base [50-23-7]; Up 200; 11uM; MCF7; HT_HG-U133A | 2.16e-04 | 194 | 64 | 5 | 3284_UP | |
| Drug | Rolipram [61413-54-5]; Down 200; 14.6uM; MCF7; HT_HG-U133A | 2.16e-04 | 194 | 64 | 5 | 5330_DN | |
| Drug | Mephenytoin [50-12-4]; Down 200; 18.4uM; MCF7; HT_HG-U133A | 2.22e-04 | 195 | 64 | 5 | 3580_DN | |
| Drug | 5279552; Down 200; 22uM; MCF7; HT_HG-U133A_EA | 2.22e-04 | 195 | 64 | 5 | 843_DN | |
| Drug | Pentamidine isethionate [140-64-7]; Down 200; 6.8uM; MCF7; HT_HG-U133A | 2.22e-04 | 195 | 64 | 5 | 4396_DN | |
| Drug | Atropine sulfate monohydrate [5908-99-6]; Down 200; 5.8uM; MCF7; HT_HG-U133A | 2.22e-04 | 195 | 64 | 5 | 2761_DN | |
| Drug | Glibenclamide [10238-21-8]; Down 200; 8uM; MCF7; HT_HG-U133A | 2.22e-04 | 195 | 64 | 5 | 3163_DN | |
| Drug | Phenazopyridine hydrochloride [136-40-3]; Down 200; 16uM; MCF7; HT_HG-U133A | 2.22e-04 | 195 | 64 | 5 | 6234_DN | |
| Drug | Flupentixol dihydrochloride cis-(Z) [2413-38-9]; Down 200; 7.8uM; MCF7; HT_HG-U133A | 2.22e-04 | 195 | 64 | 5 | 5307_DN | |
| Drug | Iproniazide phosphate [305-33-9]; Down 200; 14.4uM; PC3; HT_HG-U133A | 2.22e-04 | 195 | 64 | 5 | 2125_DN | |
| Drug | Amethopterin (R,S) [59-05-2]; Down 200; 8.8uM; PC3; HT_HG-U133A | 2.22e-04 | 195 | 64 | 5 | 6654_DN | |
| Drug | prostaglandin E2; Down 200; 10uM; MCF7; HT_HG-U133A | 2.22e-04 | 195 | 64 | 5 | 6552_DN | |
| Drug | Hydroquinine hydrobromide hydrate [304695-81-6]; Up 200; 9.4uM; MCF7; HT_HG-U133A | 2.22e-04 | 195 | 64 | 5 | 2767_UP | |
| Drug | Ramipril [87333-19-5]; Up 200; 9.6uM; PC3; HT_HG-U133A | 2.22e-04 | 195 | 64 | 5 | 7144_UP | |
| Drug | Diperodon hydrochloride [537-12-2]; Up 200; 9.2uM; HL60; HG-U133A | 2.22e-04 | 195 | 64 | 5 | 1575_UP | |
| Drug | Vidarabine [5536-17-4]; Down 200; 15uM; PC3; HT_HG-U133A | 2.22e-04 | 195 | 64 | 5 | 5850_DN | |
| Drug | Butylparaben [94-26-8]; Down 200; 20.6uM; MCF7; HT_HG-U133A | 2.22e-04 | 195 | 64 | 5 | 5245_DN | |
| Drug | CP-645525-01 [287190-82-3]; Down 200; 10uM; PC3; HT_HG-U133A | 2.27e-04 | 196 | 64 | 5 | 7527_DN | |
| Drug | Metanephrine hydrochloride DL [881-95-8]; Up 200; 17.2uM; HL60; HG-U133A | 2.27e-04 | 196 | 64 | 5 | 2015_UP | |
| Drug | Betulinic acid [472-15-1]; Down 200; 8.8uM; PC3; HT_HG-U133A | 2.27e-04 | 196 | 64 | 5 | 4101_DN | |
| Drug | Norfloxacin [70458-96-7]; Down 200; 12.6uM; PC3; HT_HG-U133A | 2.27e-04 | 196 | 64 | 5 | 2090_DN | |
| Drug | Enoxacin [74011-58-8]; Down 200; 12.4uM; PC3; HT_HG-U133A | 2.27e-04 | 196 | 64 | 5 | 4655_DN | |
| Drug | Canrenoic acid potassium salt [2181-04-6]; Down 200; 10uM; PC3; HT_HG-U133A | 2.27e-04 | 196 | 64 | 5 | 2065_DN | |
| Drug | Ribostamycin sulfate salt [53797-35-6]; Down 200; 7.2uM; PC3; HT_HG-U133A | 2.27e-04 | 196 | 64 | 5 | 7123_DN | |
| Drug | aspirin, USP; Down 200; 100uM; HL60; HT_HG-U133A | 2.32e-04 | 197 | 64 | 5 | 1145_DN | |
| Drug | Mephenytoin [50-12-4]; Down 200; 18.4uM; MCF7; HT_HG-U133A | 2.32e-04 | 197 | 64 | 5 | 6275_DN | |
| Drug | Serotonin hydrochloride [153-98-0]; Down 200; 18.8uM; PC3; HT_HG-U133A | 2.32e-04 | 197 | 64 | 5 | 4673_DN | |
| Drug | Sulfamonomethoxine [1220-83-3]; Up 200; 14.2uM; PC3; HT_HG-U133A | 2.32e-04 | 197 | 64 | 5 | 5843_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.32e-04 | 197 | 64 | 5 | 3566_DN | |
| Drug | Chloramphenicol [56-75-7]; Up 200; 12.4uM; PC3; HT_HG-U133A | 2.32e-04 | 197 | 64 | 5 | 1795_UP | |
| Drug | Norgestrel-(-)-D [797-63-7]; Down 200; 12.8uM; MCF7; HT_HG-U133A | 2.32e-04 | 197 | 64 | 5 | 3406_DN | |
| Drug | 2-Aminobenzenesulfonamide [3306-62-5]; Up 200; 23.2uM; HL60; HT_HG-U133A | 2.32e-04 | 197 | 64 | 5 | 3063_UP | |
| Drug | PNU-0293363 [326823-19-2]; Up 200; 10uM; PC3; HT_HG-U133A | 2.32e-04 | 197 | 64 | 5 | 6563_UP | |
| Drug | Carbarsone [121-59-5]; Down 200; 15.4uM; MCF7; HT_HG-U133A | 2.32e-04 | 197 | 64 | 5 | 3250_DN | |
| Drug | Lymecycline [992-21-2]; Down 200; 6.6uM; MCF7; HT_HG-U133A | 2.32e-04 | 197 | 64 | 5 | 5994_DN | |
| Drug | Diethylcarbamazine citrate [1642-54-2]; Down 200; 10.2uM; HL60; HT_HG-U133A | 2.38e-04 | 198 | 64 | 5 | 2394_DN | |
| Drug | Butacaine [149-16-6]; Down 200; 13uM; MCF7; HT_HG-U133A | 2.38e-04 | 198 | 64 | 5 | 6225_DN | |
| Drug | Methocarbamol [532-03-6]; Up 200; 16.6uM; PC3; HT_HG-U133A | 2.38e-04 | 198 | 64 | 5 | 2111_UP | |
| Drug | Tacrine hydrochloride hydrate [1684-40-8]; Down 200; 15.8uM; MCF7; HT_HG-U133A | 2.38e-04 | 198 | 64 | 5 | 2633_DN | |
| Drug | ICI 182,780; Up 200; 1uM; MCF7; HT_HG-U133A | 2.38e-04 | 198 | 64 | 5 | 6925_UP | |
| Drug | Trichlorfon [52-68-6]; Down 200; 15.6uM; HL60; HT_HG-U133A | 2.38e-04 | 198 | 64 | 5 | 1839_DN | |
| Drug | Ketoconazole [65277-42-1]; Down 200; 7.6uM; MCF7; HT_HG-U133A | 2.38e-04 | 198 | 64 | 5 | 2640_DN | |
| Drug | Bendroflumethiazide [73-48-3]; Down 200; 9.4uM; HL60; HT_HG-U133A | 2.38e-04 | 198 | 64 | 5 | 2555_DN | |
| Drug | Proparacaine hydrochloride [5875-06-9]; Down 200; 12uM; PC3; HT_HG-U133A | 2.38e-04 | 198 | 64 | 5 | 6332_DN | |
| Drug | Chlorhexidine [55-56-1]; Down 200; 8uM; MCF7; HT_HG-U133A | 2.38e-04 | 198 | 64 | 5 | 1525_DN | |
| Drug | Hexylcaine hydrochloride [532-76-3]; Down 200; 13.4uM; PC3; HT_HG-U133A | 2.38e-04 | 198 | 64 | 5 | 5768_DN | |
| Drug | Proparacaine hydrochloride [5875-06-9]; Down 200; 12uM; MCF7; HT_HG-U133A | 2.38e-04 | 198 | 64 | 5 | 5433_DN | |
| Drug | Ricinine [524-40-3]; Up 200; 24.4uM; MCF7; HT_HG-U133A | 2.38e-04 | 198 | 64 | 5 | 6206_UP | |
| Drug | Chlorpropamide [94-20-2]; Up 200; 14.4uM; PC3; HT_HG-U133A | 2.38e-04 | 198 | 64 | 5 | 6291_UP | |
| Drug | Butamben [94-25-7]; Up 200; 20.6uM; HL60; HT_HG-U133A | 2.38e-04 | 198 | 64 | 5 | 2531_UP | |
| Drug | Serotonin hydrochloride [153-98-0]; Up 200; 18.8uM; HL60; HT_HG-U133A | 2.43e-04 | 199 | 64 | 5 | 2449_UP | |
| Drug | Leucomisine [17946-87-1]; Up 200; 16.2uM; MCF7; HT_HG-U133A | 2.43e-04 | 199 | 64 | 5 | 3546_UP | |
| Drug | Ricinine [524-40-3]; Down 200; 24.4uM; PC3; HT_HG-U133A | 2.43e-04 | 199 | 64 | 5 | 5725_DN | |
| Drug | Perphenazine [58-39-9]; Down 200; 10uM; PC3; HT_HG-U133A | 2.43e-04 | 199 | 64 | 5 | 4637_DN | |
| Disease | Sezary Syndrome | 2.80e-07 | 27 | 61 | 4 | C0036920 | |
| Disease | Carcinoma, Transitional Cell | 1.58e-06 | 41 | 61 | 4 | C0007138 | |
| Disease | Menke-Hennekam syndrome | 4.20e-06 | 2 | 61 | 2 | cv:C5681632 | |
| Disease | Rubinstein-Taybi syndrome (implicated_via_orthology) | 4.20e-06 | 2 | 61 | 2 | DOID:1933 (implicated_via_orthology) | |
| Disease | Rubinstein-Taybi syndrome | 4.20e-06 | 2 | 61 | 2 | cv:C0035934 | |
| Disease | Kleefstra syndrome 2 (implicated_via_orthology) | 4.20e-06 | 2 | 61 | 2 | DOID:0080598 (implicated_via_orthology) | |
| Disease | RUBINSTEIN-TAYBI SYNDROME 1 | 4.20e-06 | 2 | 61 | 2 | C4551859 | |
| Disease | RUBINSTEIN-TAYBI SYNDROME 1 | 4.20e-06 | 2 | 61 | 2 | 180849 | |
| Disease | Rubinstein-Taybi syndrome due to CREBBP mutations | 4.20e-06 | 2 | 61 | 2 | cv:C4551859 | |
| Disease | Rubinstein-Taybi syndrome (is_implicated_in) | 4.20e-06 | 2 | 61 | 2 | DOID:1933 (is_implicated_in) | |
| Disease | Rubinstein-Taybi Syndrome | 4.20e-06 | 2 | 61 | 2 | C0035934 | |
| Disease | T-Cell Lymphoma | 4.62e-06 | 16 | 61 | 3 | C0079772 | |
| Disease | Bladder Neoplasm | 1.08e-05 | 140 | 61 | 5 | C0005695 | |
| Disease | Malignant neoplasm of urinary bladder | 1.11e-05 | 141 | 61 | 5 | C0005684 | |
| Disease | Klatskin's tumor (is_implicated_in) | 4.19e-05 | 5 | 61 | 2 | DOID:4927 (is_implicated_in) | |
| Disease | Squamous cell carcinoma of esophagus | 4.57e-05 | 95 | 61 | 4 | C0279626 | |
| Disease | Adenoid Cystic Carcinoma | 5.59e-05 | 100 | 61 | 4 | C0010606 | |
| Disease | mood instability measurement | 1.46e-04 | 128 | 61 | 4 | EFO_0008475 | |
| Disease | Diffuse Large B-Cell Lymphoma | 2.04e-04 | 55 | 61 | 3 | C0079744 | |
| Disease | gastric adenocarcinoma (is_implicated_in) | 2.28e-04 | 11 | 61 | 2 | DOID:3717 (is_implicated_in) | |
| Disease | Prostatic Neoplasms | 2.74e-04 | 616 | 61 | 7 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 2.74e-04 | 616 | 61 | 7 | C0376358 | |
| Disease | prostate cancer (is_marker_for) | 3.10e-04 | 156 | 61 | 4 | DOID:10283 (is_marker_for) | |
| Disease | breast carcinoma (is_marker_for) | 3.51e-04 | 66 | 61 | 3 | DOID:3459 (is_marker_for) | |
| Disease | congenital heart disease (implicated_via_orthology) | 4.00e-04 | 69 | 61 | 3 | DOID:1682 (implicated_via_orthology) | |
| Disease | Lymphoma, Large-Cell, Follicular | 4.34e-04 | 15 | 61 | 2 | C0079745 | |
| Disease | Lymphoma, Small Cleaved-Cell, Follicular | 4.34e-04 | 15 | 61 | 2 | C0079765 | |
| Disease | Lymphoma, Mixed-Cell, Follicular | 4.34e-04 | 15 | 61 | 2 | C0079758 | |
| Disease | Lymphoma, Follicular, Grade 2 | 4.34e-04 | 15 | 61 | 2 | C1956132 | |
| Disease | Lymphoma, Follicular, Grade 3 | 4.34e-04 | 15 | 61 | 2 | C1956131 | |
| Disease | Lymphoma, Follicular, Grade 1 | 4.34e-04 | 15 | 61 | 2 | C1956130 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 7.19e-04 | 195 | 61 | 4 | DOID:1574 (implicated_via_orthology) | |
| Disease | Lymphoma, Follicular | 7.80e-04 | 20 | 61 | 2 | C0024301 | |
| Disease | Left Ventricle Remodeling | 8.61e-04 | 21 | 61 | 2 | C0600520 | |
| Disease | Ventricular Remodeling | 8.61e-04 | 21 | 61 | 2 | C0600519 | |
| Disease | sex interaction measurement, bilirubin measurement | 9.46e-04 | 22 | 61 | 2 | EFO_0004570, EFO_0008343 | |
| Disease | glioma | 9.46e-04 | 22 | 61 | 2 | EFO_0005543 | |
| Disease | risk-taking behaviour | 9.84e-04 | 764 | 61 | 7 | EFO_0008579 | |
| Disease | Intrahepatic Cholangiocarcinoma | 1.13e-03 | 24 | 61 | 2 | C0345905 | |
| Disease | Extrahepatic Cholangiocarcinoma | 1.13e-03 | 24 | 61 | 2 | C3805278 | |
| Disease | Cholangiocarcinoma | 1.32e-03 | 26 | 61 | 2 | C0206698 | |
| Disease | Carcinoma, Granular Cell | 1.80e-03 | 116 | 61 | 3 | C0205644 | |
| Disease | Adenocarcinoma, Tubular | 1.80e-03 | 116 | 61 | 3 | C0205645 | |
| Disease | Adenocarcinoma, Oxyphilic | 1.80e-03 | 116 | 61 | 3 | C0205642 | |
| Disease | Carcinoma, Cribriform | 1.80e-03 | 116 | 61 | 3 | C0205643 | |
| Disease | Adenocarcinoma, Basal Cell | 1.80e-03 | 116 | 61 | 3 | C0205641 | |
| Disease | Adenocarcinoma | 1.80e-03 | 116 | 61 | 3 | C0001418 | |
| Disease | atopic eczema | 1.85e-03 | 252 | 61 | 4 | EFO_0000274 | |
| Disease | seasonal allergic rhinitis | 2.00e-03 | 32 | 61 | 2 | EFO_0003956 | |
| Disease | blood pressure, chronic obstructive pulmonary disease | 2.00e-03 | 32 | 61 | 2 | EFO_0000341, EFO_0004325 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GVGGPGQVMASQAQQ | 96 | Q09472 | |
| GMLAAGNGQGIMPNQ | 176 | Q09472 | |
| GNGQGIMPNQVMNGS | 181 | Q09472 | |
| QGNMGQIGQLPQALG | 2236 | Q09472 | |
| PGGGGTQTQQQMNQL | 31 | P26196 | |
| LDQMNQDGGGGDVGN | 46 | Q9HCK8 | |
| MGQQVGRVGEAPGLQ | 1 | P42684 | |
| IPNRQINDGMGGDGD | 51 | Q00994 | |
| VPPGNGNIGNMQVVA | 356 | Q5T8D3 | |
| GNIGNMQVVAVEGKG | 361 | Q5T8D3 | |
| AQMGQLGQMGQPGLG | 2266 | Q92793 | |
| NMGNGTVFLGIPGDN | 321 | P55895 | |
| GQGDVGQLGLGENVM | 41 | P18754 | |
| FGENKMGQLGLGNQT | 226 | Q9P258 | |
| QMLNEPVQEAGGQGG | 326 | P54727 | |
| GQLGMVQPGIGQQGM | 741 | Q9H0J4 | |
| NAELGGPFDQMNGVA | 41 | P11161 | |
| QPTRVVQGMGQGTEG | 1076 | Q9H0B3 | |
| AGGNVNVEMNATPGV | 236 | Q7Z3Y9 | |
| NMLAFQPTHLQGGGG | 96 | A6NI15 | |
| GQGINSMAGMINPQG | 931 | O14497 | |
| MGGPIQASAEVAQQG | 1481 | O14497 | |
| MQGSGGQLNFGLPVA | 1286 | P10071 | |
| GAGRPGQQMLGQISA | 1336 | P10071 | |
| PAEGLQTLGAQMQGG | 3816 | Q8NEZ4 | |
| LGAGNGNLQGPRHMQ | 376 | P43243 | |
| LNNPADQMDVIGVGG | 346 | Q14703 | |
| LNMQLSDGGQGDVPV | 536 | Q14C86 | |
| AAGGNVNVEMNAAPG | 236 | Q7Z3Y8 | |
| AAGGNVNVEMNAAPG | 231 | Q7Z3Z0 | |
| RGQGGMKANNNVFEP | 186 | Q9UQ05 | |
| LQQLMVRGGPAGGQN | 46 | Q6ZTU2 | |
| VRGGPAGGQNMNVDL | 51 | Q6ZTU2 | |
| AGGQNMNVDLQGVGP | 56 | Q6ZTU2 | |
| MNVDLQGVGPGLQGS | 61 | Q6ZTU2 | |
| GPIDVGQEGQLSQMA | 16 | Q9NQ87 | |
| KLEQQQRGMGGQQAP | 551 | Q71SY5 | |
| GASGQGGQSQAAEIM | 611 | O75676 | |
| GQQTIPNGLGMGGQH | 351 | Q6P9B6 | |
| LVAGEMGQNEPDQGG | 131 | Q99714 | |
| MGQNEPDQGGQRGVI | 136 | Q99714 | |
| NARIQKAQGMPEGGG | 311 | O95140 | |
| QHAGGQGAGPPQNQM | 556 | Q14686 | |
| QPEFVAGMGQDGIVQ | 456 | Q93033 | |
| APNQEGMVQAGGQGH | 11 | Q8N9R0 | |
| VGQMGSPGQQGASTQ | 1266 | Q9P218 | |
| GEIGPQGIMGQKGDQ | 376 | Q14055 | |
| SLGGGCNMIQPVNAA | 1156 | Q3T8J9 | |
| KPINMENLPVNGGNG | 411 | Q8IW92 | |
| GGMQGAGIQGVSIQG | 526 | Q9H0L4 | |
| MADRDGGQNGFNIPQ | 891 | Q9NQC7 | |
| GESMSPGQGRNNNGL | 1491 | Q92736 | |
| ERNLAVNPQGGNTGM | 121 | Q8N465 | |
| QFLDEMKGQGGAGGQ | 661 | Q9NZ71 | |
| PQNLAMGAGAVGALQ | 46 | Q9HB19 | |
| GNMNPEGGVNHENGM | 46 | Q8NHV9 | |
| MIPEGGGGNQEPRQQ | 66 | Q8NHV9 | |
| NMGNQNGNPTGTLGA | 136 | Q9HCJ0 | |
| PQQGGGRGGEMQVEA | 91 | Q9UPU3 | |
| GNIGGQFGTGINPQM | 1211 | Q15788 | |
| NMAGQLGGQQGLVLT | 126 | P78424 | |
| VSGQGPVMENAQGLG | 136 | Q9BXW7 | |
| MGNVLQGGEGQAPTR | 91 | P24752 | |
| VGLNQMVPQIEGNTG | 876 | Q9C0B9 | |
| QQMLLEGGVNQEDGP | 451 | O94967 | |
| PGGALMQGGTQQAIN | 436 | P32780 | |
| GNGLQNPEPRGANMS | 241 | Q15697 | |
| NMPQGGGQHYQGQQP | 216 | Q15532 | |
| SHGGQGPPEGMNQQY | 276 | Q15532 | |
| MPQLNGGGGDDLGAN | 1 | Q9NQB0 | |
| GGYGNLLMNSEQPQG | 661 | Q5SRE5 | |
| GIQPMGQDSGSQAQG | 196 | Q9ULM0 | |
| GEAIGKMQQQGIPGG | 141 | P51814 | |
| GVGNTAAQPRGMQQP | 1336 | Q8NDV7 | |
| VLQNVGGGEAGPQEM | 801 | Q5EBL2 | |
| MLSGQHGGQAGLVPQ | 3356 | O14686 | |
| QGSIGVAPGMNRQQV | 3441 | O14686 |